Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias
Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on...
Saved in:
Published in | Journal of lipid research Vol. 17; no. 2; pp. 125 - 131 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.1976
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0022-2275 1539-7262 |
DOI | 10.1016/S0022-2275(20)36996-0 |
Cover
Loading…
Abstract | Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum from normal subjects was twice as high in very low density lipoprotein (VLDL) (d < than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined. |
---|---|
AbstractList | Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum normal subjects was twice as high in very low density lipoprotein (VLDL) (d less than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined.Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum normal subjects was twice as high in very low density lipoprotein (VLDL) (d less than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined. Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum normal subjects was twice as high in very low density lipoprotein (VLDL) (d less than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined. Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum from normal subjects was twice as high in very low density lipoprotein (VLDL) (d < than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined. |
Author | Kruski, A W Dawson, G Scanu, A M |
Author_xml | – sequence: 1 givenname: G surname: Dawson fullname: Dawson, G organization: Departments of Pediatrics, Biochemistry and Medicine, University of Chicago, Pritzker School of Medicine and the Franklin McLean Memorial Research Institute, Chicago, Illinois 60637 – sequence: 2 givenname: A W surname: Kruski fullname: Kruski, A W organization: Departments of Pediatrics, Biochemistry and Medicine, University of Chicago, Pritzker School of Medicine and the Franklin McLean Memorial Research Institute, Chicago, Illinois 60637 – sequence: 3 givenname: A M surname: Scanu fullname: Scanu, A M organization: Departments of Pediatrics, Biochemistry and Medicine, University of Chicago, Pritzker School of Medicine and the Franklin McLean Memorial Research Institute, Chicago, Illinois 60637 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/178813$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUuPFCEUhYkZHz2j_0ATVkYXpUBBQWUWxoyvSSZxoa4JDbe66VRBCZSml_5z6e7JmLiZFXA559zkfOfoLMQACL2g5A0ltHv7jRDGGsakeMXI67br-64hD9CKirZvJOvYGVrdSZ6g85x3hFDOO_oYPaJSKdqu0J8PPpfk10vxMeA44M24tzHPWx82cfSzdxn7gMsWcIa0TLjO4pxiAR_yQR9imsyIt8tkAs7Lege2ZGyCw7MpHkJ9_PZli7f7OTbHeb1BOkbD5E1-ih4OZszw7Pa8QD8-ffx-9aW5-fr5-ur9TWM5ZaQRkhPHlaCD5JIxrqzjnVOSuLYdhGNqkNYaagRZCyuJATZI0w22VdKQoWftBbo-5bpodnpOfjJpr6Px-jiIaaNNKt6OoFkv6kpwhJqeq5YqCgJqrbLrnOGDqlkvT1m1iZ8L5KInny2MowkQl6xVy5lghFbh81vhsp7A3a091V-_xenbpphzguGfgOgDZH2ErA8ENSP6CFmT6rv8z2d9MQeEJRk_3ut-d3JDrfuXh6SzraQsOJ8qvdqHvyfhL7VuwgI |
CitedBy_id | crossref_primary_10_1096_fj_08_117150 crossref_primary_10_1155_2018_9025841 crossref_primary_10_1073_pnas_2120489119 crossref_primary_10_1007_s11892_009_0085_7 crossref_primary_10_1016_0005_2760_85_90273_5 crossref_primary_10_1016_S0021_9258_18_35871_X crossref_primary_10_1517_17530059_2013_846322 crossref_primary_10_1128_JCM_39_2_798_800_2001 crossref_primary_10_1016_S0021_9258_18_37665_8 crossref_primary_10_1016_j_bbalip_2010_11_003 crossref_primary_10_1016_S0021_9258_19_70102_1 crossref_primary_10_1038_35089558 crossref_primary_10_1042_CS20090452 crossref_primary_10_1016_0003_9861_85_90179_1 crossref_primary_10_1016_j_tcm_2005_08_005 crossref_primary_10_1056_NEJM197704142961521 crossref_primary_10_1007_BF00731466 crossref_primary_10_1007_s00394_015_0879_0 crossref_primary_10_1016_j_atherosclerosis_2012_08_041 crossref_primary_10_1016_j_isci_2024_111051 crossref_primary_10_1016_j_jacl_2013_08_001 crossref_primary_10_1016_0005_2760_82_90112_6 crossref_primary_10_1586_14779072_3_6_1071 crossref_primary_10_1016_S0021_9258_19_68819_8 crossref_primary_10_1194_jlr_M006759 crossref_primary_10_1016_j_cca_2013_12_001 crossref_primary_10_1016_j_tcm_2007_02_006 crossref_primary_10_1016_S0021_9258_18_33664_0 crossref_primary_10_1006_bbrc_2002_6356 crossref_primary_10_1007_BF01311096 crossref_primary_10_1194_jlr_D062083 crossref_primary_10_3390_diseases6030082 crossref_primary_10_1007_s40620_015_0193_1 crossref_primary_10_1194_jlr_R036095 crossref_primary_10_1016_0005_2760_92_90043_U crossref_primary_10_1016_S0022_2275_20_38394_2 crossref_primary_10_1016_S0021_9258_19_68820_4 crossref_primary_10_1182_blood_V97_7_1907 crossref_primary_10_1002_psp4_12506 crossref_primary_10_1016_S0022_2275_20_37285_0 crossref_primary_10_1194_jlr_M087502 crossref_primary_10_1111_j_1399_0004_1984_tb00799_x crossref_primary_10_1016_0009_8981_83_90230_9 crossref_primary_10_1161_CIRCULATIONAHA_114_010006 crossref_primary_10_1016_0005_2760_85_90082_7 crossref_primary_10_1016_0161_5890_84_90118_4 crossref_primary_10_1016_S0021_9258_19_81070_0 crossref_primary_10_1111_j_1432_1033_1978_tb12363_x crossref_primary_10_1161_ATVBAHA_109_201673 crossref_primary_10_1016_0005_2744_78_90359_5 crossref_primary_10_1016_0021_9150_92_90235_9 crossref_primary_10_1074_jbc_RA118_005876 crossref_primary_10_1161_01_ATV_18_10_1523 crossref_primary_10_1016_0009_8981_77_90511_3 crossref_primary_10_1111_j_1471_4159_1989_tb09199_x crossref_primary_10_1002_1531_8249_200002_47_2_229__AID_ANA13_3_0_CO_2_T crossref_primary_10_1016_0014_5793_96_00392_4 crossref_primary_10_1161_CIRCULATIONAHA_113_007559 crossref_primary_10_1016_j_atherosclerosis_2007_09_018 crossref_primary_10_1016_0021_9150_80_90081_7 crossref_primary_10_3390_nu16193296 crossref_primary_10_1074_jbc_M115_659110 crossref_primary_10_1016_j_tem_2017_03_005 crossref_primary_10_1002_rth2_12017 crossref_primary_10_2217_clp_12_14 crossref_primary_10_1073_pnas_1415357111 crossref_primary_10_1016_0005_2795_81_90250_6 crossref_primary_10_1111_j_1423_0410_1981_tb00665_x crossref_primary_10_1006_abio_1998_2966 crossref_primary_10_1016_S0022_2275_20_39890_4 crossref_primary_10_1007_BF02534789 crossref_primary_10_1128_CVI_00060_08 crossref_primary_10_1111_j_1471_4159_1988_tb01049_x crossref_primary_10_1016_j_bbrc_2020_02_104 crossref_primary_10_1016_0005_2760_78_90158_3 crossref_primary_10_1194_jlr_E800005_JLR200 crossref_primary_10_1016_S0165_5728_99_00203_9 crossref_primary_10_5551_jat_13_281 crossref_primary_10_1016_S0022_2275_20_40115_4 crossref_primary_10_3389_fcell_2021_658995 crossref_primary_10_1016_S0021_9258_18_67044_9 crossref_primary_10_1016_S0022_2275_20_41686_4 crossref_primary_10_1016_0304_4165_79_90391_X crossref_primary_10_1016_S0022_2275_20_38115_3 crossref_primary_10_1016_j_biomaterials_2015_06_001 |
Cites_doi | 10.1172/JCI107578 10.1016/S0022-2275(20)39414-1 10.1016/S0021-9258(18)63406-4 10.1016/0006-291X(74)90426-4 10.1016/0003-2697(71)90247-8 10.1042/bj1040340 10.1172/JCI107333 10.1056/NEJM196702022760507 10.1016/S0022-2275(20)38884-2 10.1016/S0021-9258(19)52451-6 10.1212/WNL.24.11.1051 10.1016/0006-3002(63)90773-X 10.1016/S0022-2275(20)42667-7 10.1016/S0021-9258(18)70226-3 10.1126/science.164.3879.553 10.1016/S0065-2423(08)60345-5 10.1016/0009-8981(68)90135-6 10.1016/S0021-9258(18)64849-5 10.1016/0005-2760(70)90159-1 10.1016/S0022-2275(20)39374-3 |
ContentType | Journal Article |
Copyright | 1976 © 1976 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. |
Copyright_xml | – notice: 1976 © 1976 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.1016/S0022-2275(20)36996-0 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1539-7262 |
EndPage | 131 |
ExternalDocumentID | oai_doaj_org_article_295120ed01a9483181e5e153766da4f8 178813 10_1016_S0022_2275_20_36996_0 S0022227520369960 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
GroupedDBID | --- -~X .55 .GJ 0SF 0VX 18M 29K 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6I. AAEDW AAFTH AAFWJ AAXUO AAYOK ABCQX ABOCM ACCCW ACGFO ACKIV ACNCT ACPRK ADBBV AENEX AEXQZ AFFNX AFOSN AFPKN AHPSJ AI. ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BTFSW C1A CS3 D-I DIK DU5 E3Z EBS EJD F5P FDB FRP GROUPED_DOAJ GX1 H13 HH5 HYE H~9 J5H KQ8 L7B MVM OK1 P2P RHF RHI ROL RPM TBC TR2 TWZ VH1 W8F WH7 WOQ X7M XFK YHG YKV ZA5 ZGI ZXP ~KM 0R~ AALRI AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFPUW AIGII AITUG AKBMS AKRWK AKYEP CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c4120-5740d4851f7472248cd46d870d33f5d28f7cca1a50b5c70ae2f7a6fc387a0f923 |
IEDL.DBID | DOA |
ISSN | 0022-2275 |
IngestDate | Wed Aug 27 01:29:22 EDT 2025 Fri Jul 11 01:11:14 EDT 2025 Thu Jan 02 22:56:50 EST 2025 Tue Jul 01 01:14:45 EDT 2025 Thu Apr 24 23:05:50 EDT 2025 Fri Feb 23 02:45:54 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | gas-liquid chromatography mixed hyperlipoproteinemias abetalipoproteinemia hypobetalipoproteinemia familial hypercholesterolemia Tangier disease serum glycosphingolipids |
Language | English |
License | This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0 https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4120-5740d4851f7472248cd46d870d33f5d28f7cca1a50b5c70ae2f7a6fc387a0f923 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/295120ed01a9483181e5e153766da4f8 |
PMID | 178813 |
PQID | 83425201 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_295120ed01a9483181e5e153766da4f8 proquest_miscellaneous_83425201 pubmed_primary_178813 crossref_primary_10_1016_S0022_2275_20_36996_0 crossref_citationtrail_10_1016_S0022_2275_20_36996_0 elsevier_sciencedirect_doi_10_1016_S0022_2275_20_36996_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1976-Mar |
PublicationDateYYYYMMDD | 1976-03-01 |
PublicationDate_xml | – month: 03 year: 1976 text: 1976-Mar |
PublicationDecade | 1970 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of lipid research |
PublicationTitleAlternate | J Lipid Res |
PublicationYear | 1976 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Franey, Amader (bib16) 1968; 21 Scanu (bib25) 1973 Rapport, Graf (bib22) 1969; 13 Sweeley, Dawson (bib4) 1969 Bartlett (bib20) 1959; 234 Vance, Sweeley (bib2) 1967; 8 Marcus, Cass (bib6) 1969; 164 Aggerbeck, McMahon, Scanu (bib11) 1974; 24 Van Handel, Zilversmit (bib17) 1957; 50 Hazzard, Goldstein, Schrott, Motulsky, Berman (bib12) 1973; 52 Yu, Ledeen (bib5) 1972; 13 Naiki, Marcus (bib23) 1974; 60 Tao, Sweeley (bib3) 1970; 218 Skipski, Barclay, Barclay, Fetzer, Good, Archibald (bib8) 1967; 103 Fredrickson, Levy, Lees (bib13) 1967; 276 Folch, Lees, Stanley (bib18) 1957; 226 Scanu, Edelstein (bib15) 1971; 44 Dawson (bib19) 1972; 13 Dawson, Sweeley (bib9) 1970; 245 Scanu, Aggerbeck, Kruski, Lim, Kayden (bib10) 1974; 53 Scanu, Ritter (bib14) 1973; 16 Vance, Krivit, Sweeley (bib7) 1969; 10 Scanu, Kruski (bib24) 1975 Svennerholm, Svennerholm (bib1) 1963; 70 Lowry, Rosebrough, Farr, Randall (bib21) 1951; 193 Naiki (10.1016/S0022-2275(20)36996-0_bib23) 1974; 60 Scanu (10.1016/S0022-2275(20)36996-0_bib25) 1973 Aggerbeck (10.1016/S0022-2275(20)36996-0_bib11) 1974; 24 Skipski (10.1016/S0022-2275(20)36996-0_bib8) 1967; 103 Vance (10.1016/S0022-2275(20)36996-0_bib7) 1969; 10 Marcus (10.1016/S0022-2275(20)36996-0_bib6) 1969; 164 Rapport (10.1016/S0022-2275(20)36996-0_bib22) 1969; 13 Hazzard (10.1016/S0022-2275(20)36996-0_bib12) 1973; 52 Lowry (10.1016/S0022-2275(20)36996-0_bib21) 1951; 193 Scanu (10.1016/S0022-2275(20)36996-0_bib10) 1974; 53 Van Handel (10.1016/S0022-2275(20)36996-0_bib17) 1957; 50 Tao (10.1016/S0022-2275(20)36996-0_bib3) 1970; 218 Yu (10.1016/S0022-2275(20)36996-0_bib5) 1972; 13 Fredrickson (10.1016/S0022-2275(20)36996-0_bib13) 1967; 276 Scanu (10.1016/S0022-2275(20)36996-0_bib14) 1973; 16 Dawson (10.1016/S0022-2275(20)36996-0_bib9) 1970; 245 Dawson (10.1016/S0022-2275(20)36996-0_bib19) 1972; 13 Scanu (10.1016/S0022-2275(20)36996-0_bib24) 1975 Scanu (10.1016/S0022-2275(20)36996-0_bib15) 1971; 44 Folch (10.1016/S0022-2275(20)36996-0_bib18) 1957; 226 Sweeley (10.1016/S0022-2275(20)36996-0_bib4) 1969 Franey (10.1016/S0022-2275(20)36996-0_bib16) 1968; 21 Vance (10.1016/S0022-2275(20)36996-0_bib2) 1967; 8 Bartlett (10.1016/S0022-2275(20)36996-0_bib20) 1959; 234 Svennerholm (10.1016/S0022-2275(20)36996-0_bib1) 1963; 70 |
References_xml | – volume: 234 start-page: 466 year: 1959 end-page: 468 ident: bib20 article-title: Phosphorus assay in column chromatography publication-title: J. Biol. Chem. – volume: 8 start-page: 621 year: 1967 end-page: 630 ident: bib2 article-title: Quantitative determination of the neutral glycosylceramides in human blood publication-title: J. Lipid Res. – volume: 21 start-page: 255 year: 1968 end-page: 266 ident: bib16 article-title: Serum cholesterol measurement based on ethanol extraction of ferric chloride sulfuric acid publication-title: Clin. Chim. Acta. – volume: 226 start-page: 497 year: 1957 end-page: 509 ident: bib18 article-title: A simple method for the isolation and purification of total lipids from animal tissues publication-title: J. Biol. Chem. – volume: 24 start-page: 1041 year: 1974 end-page: 1063 ident: bib11 article-title: Hypobetalipoproteinemia: clinical and biochemical description of a new kindred with “Friedrich's Ataxia” publication-title: Neurology. – volume: 103 start-page: 340 year: 1967 end-page: 352 ident: bib8 article-title: Lipid composition of human serum lipoproteins publication-title: Biochem. J. – volume: 13 start-page: 680 year: 1972 end-page: 686 ident: bib5 article-title: Gangliosides of human, bovine and rabbit plasma publication-title: J. Lipid Res. – volume: 60 start-page: 1105 year: 1974 end-page: 1111 ident: bib23 article-title: Human erythrocyte P and P publication-title: Biochem. Biophys. Res. Commun. – volume: 218 start-page: 372 year: 1970 end-page: 375 ident: bib3 article-title: Occurrence of hematoside in human plasma publication-title: Biochim. Biophys. Acta. – volume: 16 start-page: 111 year: 1973 end-page: 151 ident: bib14 article-title: The proteins of plasma lipoproteins: properties and significance publication-title: Adv. Clin.Chem. – start-page: 172 year: 1969 end-page: 232 ident: bib4 article-title: Lipids of the erythrocyte publication-title: Red Cell Membrane – volume: 50 start-page: 152 year: 1957 end-page: 161 ident: bib17 article-title: Micro-method for the direct determination of serum triglycerides publication-title: J. Lab. Clin. Med. – volume: 276 start-page: 32 year: 1967 end-page: 44 ident: bib13 article-title: Fat transport in lipoproteins—an integrated approach to mechanisms and disorders publication-title: New Engl. J. Med. – volume: 53 start-page: 440 year: 1974 end-page: 453 ident: bib10 article-title: A study of the abnormal lipoproteins in abetalipoproteinemia publication-title: J. Clin. Invest. – volume: 52 start-page: 1569 year: 1973 end-page: 1577 ident: bib12 article-title: Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction publication-title: J. Clin. Invest. – volume: 13 start-page: 207 year: 1972 end-page: 219 ident: bib19 article-title: Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosylhydrolase deficiency: lactosylceramidosis publication-title: J. Lipid Res. – volume: 164 start-page: 553 year: 1969 end-page: 555 ident: bib6 article-title: Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes publication-title: Science. – volume: 10 start-page: 188 year: 1969 end-page: 192 ident: bib7 article-title: Concentrations of glycosylceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosis publication-title: J. Lipid Res. – volume: 44 start-page: 576 year: 1971 end-page: 588 ident: bib15 article-title: Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low-density and high-density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins publication-title: Anal. Biochem. – volume: 13 start-page: 273 year: 1969 end-page: 331 ident: bib22 article-title: Immunochemical reactions of lipids publication-title: Progr. Allergy. – volume: 245 start-page: 410 year: 1970 end-page: 416 ident: bib9 article-title: In vivo studies on glycosphingolipid metabolism in porcine blood publication-title: J. Biol. Chem. – volume: 193 start-page: 265 year: 1951 end-page: 275 ident: bib21 article-title: Protein measurement with Folin phenol reagent publication-title: J. Biol. Chem. – volume: 70 start-page: 432 year: 1963 end-page: 438 ident: bib1 article-title: The separation of neutral blood serum glycolipid by TLC publication-title: Biochim. Biophys. Acta. – start-page: 21 year: 1975 end-page: 38 ident: bib24 article-title: The chemistry of serum lipoproteins publication-title: International Encyclopedia of Pharmacology and Therapeutics – start-page: 223 year: 1973 end-page: 246 ident: bib25 article-title: The structure of human serum low and high density lipoproteins publication-title: Atherogenesis Initiating Factors. CIBA Fdn. Symp. 12 – volume: 53 start-page: 440 year: 1974 ident: 10.1016/S0022-2275(20)36996-0_bib10 article-title: A study of the abnormal lipoproteins in abetalipoproteinemia publication-title: J. Clin. Invest. doi: 10.1172/JCI107578 – volume: 13 start-page: 207 year: 1972 ident: 10.1016/S0022-2275(20)36996-0_bib19 article-title: Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosylhydrolase deficiency: lactosylceramidosis publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)39414-1 – start-page: 172 year: 1969 ident: 10.1016/S0022-2275(20)36996-0_bib4 article-title: Lipids of the erythrocyte – volume: 245 start-page: 410 year: 1970 ident: 10.1016/S0022-2275(20)36996-0_bib9 article-title: In vivo studies on glycosphingolipid metabolism in porcine blood publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)63406-4 – volume: 13 start-page: 273 year: 1969 ident: 10.1016/S0022-2275(20)36996-0_bib22 article-title: Immunochemical reactions of lipids publication-title: Progr. Allergy. – volume: 60 start-page: 1105 year: 1974 ident: 10.1016/S0022-2275(20)36996-0_bib23 article-title: Human erythrocyte P and Pk blood group antigens: identification as glyco-sphingolipids publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(74)90426-4 – volume: 44 start-page: 576 year: 1971 ident: 10.1016/S0022-2275(20)36996-0_bib15 article-title: Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low-density and high-density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins publication-title: Anal. Biochem. doi: 10.1016/0003-2697(71)90247-8 – start-page: 21 year: 1975 ident: 10.1016/S0022-2275(20)36996-0_bib24 article-title: The chemistry of serum lipoproteins – volume: 103 start-page: 340 year: 1967 ident: 10.1016/S0022-2275(20)36996-0_bib8 article-title: Lipid composition of human serum lipoproteins publication-title: Biochem. J. doi: 10.1042/bj1040340 – volume: 52 start-page: 1569 year: 1973 ident: 10.1016/S0022-2275(20)36996-0_bib12 article-title: Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction publication-title: J. Clin. Invest. doi: 10.1172/JCI107333 – volume: 276 start-page: 32 year: 1967 ident: 10.1016/S0022-2275(20)36996-0_bib13 article-title: Fat transport in lipoproteins—an integrated approach to mechanisms and disorders publication-title: New Engl. J. Med. doi: 10.1056/NEJM196702022760507 – volume: 8 start-page: 621 year: 1967 ident: 10.1016/S0022-2275(20)36996-0_bib2 article-title: Quantitative determination of the neutral glycosylceramides in human blood publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)38884-2 – volume: 193 start-page: 265 year: 1951 ident: 10.1016/S0022-2275(20)36996-0_bib21 article-title: Protein measurement with Folin phenol reagent publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)52451-6 – volume: 24 start-page: 1041 year: 1974 ident: 10.1016/S0022-2275(20)36996-0_bib11 article-title: Hypobetalipoproteinemia: clinical and biochemical description of a new kindred with “Friedrich's Ataxia” publication-title: Neurology. doi: 10.1212/WNL.24.11.1051 – volume: 70 start-page: 432 year: 1963 ident: 10.1016/S0022-2275(20)36996-0_bib1 article-title: The separation of neutral blood serum glycolipid by TLC publication-title: Biochim. Biophys. Acta. doi: 10.1016/0006-3002(63)90773-X – volume: 50 start-page: 152 year: 1957 ident: 10.1016/S0022-2275(20)36996-0_bib17 article-title: Micro-method for the direct determination of serum triglycerides publication-title: J. Lab. Clin. Med. – start-page: 223 year: 1973 ident: 10.1016/S0022-2275(20)36996-0_bib25 article-title: The structure of human serum low and high density lipoproteins – volume: 10 start-page: 188 year: 1969 ident: 10.1016/S0022-2275(20)36996-0_bib7 article-title: Concentrations of glycosylceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosis publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)42667-7 – volume: 234 start-page: 466 year: 1959 ident: 10.1016/S0022-2275(20)36996-0_bib20 article-title: Phosphorus assay in column chromatography publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)70226-3 – volume: 164 start-page: 553 year: 1969 ident: 10.1016/S0022-2275(20)36996-0_bib6 article-title: Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes publication-title: Science. doi: 10.1126/science.164.3879.553 – volume: 16 start-page: 111 year: 1973 ident: 10.1016/S0022-2275(20)36996-0_bib14 article-title: The proteins of plasma lipoproteins: properties and significance publication-title: Adv. Clin.Chem. doi: 10.1016/S0065-2423(08)60345-5 – volume: 21 start-page: 255 year: 1968 ident: 10.1016/S0022-2275(20)36996-0_bib16 article-title: Serum cholesterol measurement based on ethanol extraction of ferric chloride sulfuric acid publication-title: Clin. Chim. Acta. doi: 10.1016/0009-8981(68)90135-6 – volume: 226 start-page: 497 year: 1957 ident: 10.1016/S0022-2275(20)36996-0_bib18 article-title: A simple method for the isolation and purification of total lipids from animal tissues publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)64849-5 – volume: 218 start-page: 372 year: 1970 ident: 10.1016/S0022-2275(20)36996-0_bib3 article-title: Occurrence of hematoside in human plasma publication-title: Biochim. Biophys. Acta. doi: 10.1016/0005-2760(70)90159-1 – volume: 13 start-page: 680 year: 1972 ident: 10.1016/S0022-2275(20)36996-0_bib5 article-title: Gangliosides of human, bovine and rabbit plasma publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)39374-3 |
SSID | ssj0014461 |
Score | 1.3298141 |
Snippet | Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human... |
SourceID | doaj proquest pubmed crossref elsevier |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 125 |
SubjectTerms | abetalipoproteinemia Abetalipoproteinemia - blood Adolescent Adult Child familial hypercholesterolemia Female gas-liquid chromatography Glycosphingolipids - blood Humans Hypercholesterolemia - blood Hypercholesterolemia - genetics Hyperlipidemias - blood hypobetalipoproteinemia Lipid Metabolism, Inborn Errors - blood Lipoproteins - blood Lipoproteins, HDL - blood Lipoproteins, LDL - blood Lipoproteins, VLDL - blood Male mixed hyperlipoproteinemias serum glycosphingolipids Sex Factors Tangier disease |
Title | Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias |
URI | https://dx.doi.org/10.1016/S0022-2275(20)36996-0 https://www.ncbi.nlm.nih.gov/pubmed/178813 https://www.proquest.com/docview/83425201 https://doaj.org/article/295120ed01a9483181e5e153766da4f8 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQOcAFQVvE8ig-IASHgONHnD0uhaqiggOiojfLiW0aaeusSPewR_45M47TpQe0F26WZTuJZ5z5xh5_Q8iruedCBakKAQpTSLBJRR0seCmNEAHMh3YeT3S_fK1Oz-XnC3XxV6ovjAkb6YHHiXvPAQJw5h0r7VzWMGDplS-RhKRyVoZ0zRds3uRM5fMDcHLKiSecc622d3fwbnCufMPZW1GlKNxbVimR998yTv8Cn8kInTwkDzJ6pIvxrR-ROz7uk4NFBM_5akNf0xTPmTbK98m94ymX2wH5_RELObUV7QP9udy0_bDC7ad-2a06N9AuUgCDFFRyfUWhrk8UDl0csH1EaLukKaMfHdYN7t4M1EZHMzHrQHFHl15uVn2R6qGETFpjAlo7HJLzk0_fj0-LnHyhaCVMeKG0ZE4CHgsa-SQlJjmqHKxuB0JUjtdBg_BLq1ijWs2s50HbKrSi1pYFgI2PyV7so39CKFLECfBLXKOsdLqcWzGvaqaU843lvJkROU2-aTMzOSbIWJptCBrIzKDMDGcmycywGXl30201UnPs6vABJXvTGJm1UwXom8n6Znbp24zUk16YDFJG8AFDdbue_3LSIwPyx5MZG32_Hkwt4NcJUGxGDkf12n4Q0v2Lp__jzZ-R-yWAzzGA7jnZu_619i8AUV03R-Tu4uzbj7OjtIj-ALLeF7c |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+of+glycosphingolipids+in+the+serum+lipoproteins+of+normal+human+subjects+and+patients+with+hypo-+and+hyperlipidemias&rft.jtitle=Journal+of+lipid+research&rft.au=Dawson%2C+G&rft.au=Kruski%2C+A+W&rft.au=Scanu%2C+A+M&rft.date=1976-03-01&rft.issn=0022-2275&rft.volume=17&rft.issue=2&rft.spage=125&rft.epage=131&rft_id=info:doi/10.1016%2FS0022-2275%2820%2936996-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S0022_2275_20_36996_0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2275&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2275&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2275&client=summon |